Sugar Crush: And Now, The Rest of the Story...
This episode explores the complicated landscape of stem cell therapy regulation in the United States, focusing on the FDA's restrictive definitions and their impact on doctors and patients. Dr. Rick Jacoby and his guest discuss the legal hurdles that drive Americans to seek treatment abroad, the role of big pharma, and the challenges of pursuing innovation. The conversation highlights the tension between scientific potential and regulatory roadblocks, leaving many to question the future of regenerative medicine in America.
68 episoder
Kommentarer
0Vær den første til at kommentere
Tilmeld dig nu og bliv en del af Sugar Crush: And Now, The Rest of the Story...-fællesskabet!